CL2007003660A1 - USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH. - Google Patents

USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH.

Info

Publication number
CL2007003660A1
CL2007003660A1 CL200703660A CL2007003660A CL2007003660A1 CL 2007003660 A1 CL2007003660 A1 CL 2007003660A1 CL 200703660 A CL200703660 A CL 200703660A CL 2007003660 A CL2007003660 A CL 2007003660A CL 2007003660 A1 CL2007003660 A1 CL 2007003660A1
Authority
CL
Chile
Prior art keywords
nocardial
nocardia
gender
vaccine
fish
Prior art date
Application number
CL200703660A
Other languages
Spanish (es)
Inventor
Luc Labrie Laura Grisez
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2007003660A1 publication Critical patent/CL2007003660A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
CL200703660A 2006-12-18 2007-12-17 USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH. CL2007003660A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06126409 2006-12-18

Publications (1)

Publication Number Publication Date
CL2007003660A1 true CL2007003660A1 (en) 2008-07-25

Family

ID=37744423

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703660A CL2007003660A1 (en) 2006-12-18 2007-12-17 USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH.

Country Status (3)

Country Link
CL (1) CL2007003660A1 (en)
TW (1) TW200843789A (en)
WO (1) WO2008074783A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200936759A (en) * 2007-12-21 2009-09-01 Intervet Int Bv Fish vaccine
CN111304131B (en) * 2020-03-17 2021-07-16 中国水产科学研究院黄海水产研究所 Pathogenic mermaid photobacterium mermaid subspecies strain and application thereof
CN112481183A (en) * 2020-12-07 2021-03-12 广东海洋大学深圳研究院 Nocardia seriolae attenuated as well as construction method and application thereof
CN113648407A (en) * 2021-08-20 2021-11-16 广东渔跃生物技术有限公司 Application of nocardia immunopotentiator in fish vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2184531B1 (en) * 1972-05-19 1975-10-17 Anvar

Also Published As

Publication number Publication date
TW200843789A (en) 2008-11-16
WO2008074783A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
ES2523968T3 (en) Antibacterial combination therapy for the treatment of infections by Gram-positive bacteria
CL2012001950A1 (en) Use of a probiotic bacterial strain in the manufacture of a medicament or nutritional composition in humans or animals to alter sleep patterns
EP2545068B8 (en) Immunogenic composition or vaccine against gram-negative bacterial, for example neiserial, infection or disease
AR072435A1 (en) NUTRITIONAL COMPOSITION FOR CHILDREN BORN BY CESAREA
BRPI1007885A2 (en) antiseptic bismutholols for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
CL2013001602A1 (en) Method to reduce or inhibit the progression of the level of fatigue in patients with multiple sclerosis and to provide them with neuroprotection comprising orally administering laquinimod or a salt thereof; laquinimod to reduce the level of fatigue, improve functional status and deliver neuroprotection in multiple sclerosis.
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
CL2014000470A1 (en) Compounds derived from 2-oxo-pyridine-3-carboxylic acid; pharmaceutical composition; combination; and its use to treat or improve a bacterial infection.
CR10075A (en) BIFENYL CARBOXAMIDS TO COMBAT MICROORGANISMS.
WO2009026657A8 (en) Flavonoid ppar agonists
BR112012002454A2 (en) improved plants, microbes and organisms
BR112013011693A2 (en) hydroxamic acid derivatives and their use in the treatment of bacterial infections
CL2013002313A1 (en) Erythromycin-derived macrolide compounds substituted in c-4 "position with methyl amino substituted with antibiotic activity; intermediary compounds; pharmaceutical composition, use in prophylaxis or treatment of bacterial infections resistant to erythromycin.
CL2012003168A1 (en) Pharmaceutical composition comprising an aqueous solution of minocycline and a divalent or trivalent cation in a ratio greater than 2: 1 with respect to the minocycline; Preparation method; kit and use in the treatment of bacterial infections.
BRPI1008517A2 (en) mir-208 and mir-499 dual targeting in the treatment of heart disease.
WO2014127351A3 (en) Compositions and methods to alter gut microbial fermentation using sulfate-reducing bacteria
CL2008003262A1 (en) Vaccine comprising Lactococcus garviae, Pasteurella piscicida, Vibrio anguillarum and Nocardia Seriouslae; and use of said bacteria to combat nocardia infections in fish.
GT200900319A (en) (OXAZOLIDINON-5-IL-METIL) -2-REPLACED THIOPHEN-CARBOXAMIDS AND ITS USE IN THE FIELD OF THE BLOOD COAGULATION
BR112017014670A2 (en) polymyxin derivative and uses thereof
EP2702142A4 (en) A method for use of biologic agents including live or dormant forms of bacteria and other organisms in treating infections, inflammation and other diseases of distal small intestine and large intestine
NI201000173A (en) USE OF DRONEDARONE OR A PHARMACEUTICALLY ACCEPTABLE SALT OF IT, FOR THE PREPARATION OF A MEDICINE TO REGULATE THE LEVEL OF POTASSIUM IN THE BLOOD.
CL2007003660A1 (en) USE OF A BACTERIA OF GENDER NOCARDIA TO MANUFACTURE A VACCINE TO COMBAT GRAM-NEGATIVE NON-NOCARDIAL BACTERIAL INFECTION IN FISH.
AR053775A1 (en) NONADEPSIPEPTIDES ACILATED II
BR112012024999A2 (en) combination and use
ECSP088907A (en) VACCINE AGAINST RICKETTSIA SIMILAR ORGANISMS